(Q35573431)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14593169%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

review article

1 reference

title

Looking backward to move forward: early detection of neurodegenerative disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14593169%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Looking Backward to Move Forward: Early Detection of Neurodegenerative Disorders (English)

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1090349

27 March 2024

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14593169%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

2

Kenneth Marek

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14593169%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

language of work or name

English

0 references

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14593169%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

31 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14593169

full work available at URL

27 March 2024

https://www.science.org/doi/pdf/10.1126/science.1090349

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1090349

27 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14593169%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

302

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14593169%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

5646

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14593169%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

830-834

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14593169%20AND%20SRC:MED&resulttype=core&format=json

Quantitative assessment of cortical synaptic density in Alzheimer's disease.

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

1H NMR spectroscopy studies of Huntington's disease: correlations with CAG repeat numbers

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

A Drosophila model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Subclinical cognitive impairment: epidemiology and clinical characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Early detection of probable idiopathic Parkinson's disease: I. Development of a diagnostic test battery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

The decline in synapses and cholinergic activity is asynchronous in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Parkinson disease in twins: an etiologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Cholinergic markers in elderly patients with early signs of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Mild cognitive impairment represents early-stage Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

In-vivo measurement of activated microglia in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Clinical markers of early disease in persons near onset of Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

New frontiers in Alzheimer's disease genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Olfactory Testing as an Aid in the Diagnosis of Parkinson's Disease: Development of Optimal Discrimination Criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Can we discover novel pathways using metabolomic analysis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Mouse and fly models of neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Serum creatinine levels correlate with plasma amyloid Beta protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Parkinson's genetics: molecular insights for the new millennium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: an 18F-dopa PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Incidence and outcome of mild cognitive impairment in a population-based prospective cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Neurological disease: UPS stops delivering!

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Altered proteasomal function in sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Plasma and cerebrospinal fluid alpha1-antichymotrypsin levels in Alzheimer's disease: correlation with cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Positron emission tomography and single-photon emission computed tomography brain imaging in the evaluation of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Significant linkage of Parkinson disease to chromosome 2q36-37

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Five-Year Follow-up of Cognitive Impairment With No Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Clinical features and neuroimaging of PARK7-linked parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Potential of human embryonic stem cells in regenerative medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Early-onset idiopathic growth hormone deficiency within KIGS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Association study of Parkin gene polymorphisms with idiopathic Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

A transgenic mouse model of the ubiquitin/proteasome system

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Dopaminergic function in familial Parkinson's disease: A clinical and18F-dopa positron emission tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Neurobiology. Of flies and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

The dopamine transporter is absent in parkinsonian putamen and reduced in the caudate nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Can imaging distinguish PSP from other neurodegenerative disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1090349

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1090349

Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease

27 March 2024

3

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1090349

Accuracy of family history data on Parkinson's disease

27 March 2024

7

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1090349

Validity of family history data on PD: evidence for a family information bias

27 March 2024

8

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1090349

Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.

27 March 2024

24

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1090349

Parkinsonism: onset, progression, and mortality

27 March 2024

29

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1090349

Clinical and [18F] dopa PET findings in early Parkinson's disease

27 March 2024

31

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1090349

The binding of 2-(4'-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component.

27 March 2024

37

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1090349

Radioiodinated styrylbenzene derivatives as potential SPECT imaging agents for amyloid plaque detection in Alzheimer's disease

27 March 2024

38

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1090349

Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease

27 March 2024

42

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1090349

Alzheimer's disease: a correlative study

27 March 2024

65

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1090349

Early detection of probable idiopathic Parkinson's disease: I. development of a diagnostic test battery

27 March 2024

71

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1090349

Bioinformatics in the post-sequence era.

27 March 2024

81

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1090349